¹é½Å º¸Á¶Á¦ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : À¯Çüº°, Åõ¿© ¹æ¹ýº°, ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Vaccine Adjuvants Market Size, Share & Trends Analysis Report By Type (Pathogen, Adjuvant Emulsion, Particulate), By Administration (Oral, Intradermal, Intranasal, Intramuscular), By Application, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1631493
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 120 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,443,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,862,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,700,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹é½Å º¸Á¶Á¦ ½ÃÀå ¼ºÀå ¹× µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¼¼°è ¹é½Å º¸Á¶Á¦ ½ÃÀåÀº 2030³â±îÁö 48¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀåÀº 2025-2030³â±îÁö ¿¬Æò±Õ 4.32%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Çõ½ÅÀûÀÎ ¹é½Å Ç׿øÀÇ ºÒÃæºÐÇÑ ¸é¿ª¿ø¼ºÀ¸·Î ÀÎÇØ ¹é½Å °³¹ß¿¡¼­ º¸Á¶Á¦ ¿¬±¸ÀÇ Á߿伺ÀÌ Á¡Â÷ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±âÁ¸ ¹× ½ÅÈï Áúº´¿¡ ´ëÇÑ ¸é¿ª È¿°ú¸¦ Àå±â°£ Áö¼Ó½ÃŰ´Â °Í¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¹é½Å º¸Á¶Á¦¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

NCBI¿¡ µû¸£¸é ¸Å³â ¾à 15,000¸íÀÇ ¿©¼ºÀÌ ÀڱðæºÎ¾ÏÀ¸·Î »ç¸ÁÇϰí ÀÖÀ¸¸ç, GSKÀÇ AS04 º¸Á¶Á¦(ÀÎÀ¯µÎÁ¾¹ÙÀÌ·¯½º ¹é½Å)¿Í °°ÀÌ ¸é¿ª¹ÝÀÀÀ» ¿À·¡ Áö¼Ó½ÃŰ´Â º¸Á¶Á¦¸¦ °³¹ßÇÏ´Â ±â¾÷µµ ÀÖ½À´Ï´Ù. À» °³¹ßÇÏ´Â ±â¾÷µµ ÀÖ½À´Ï´Ù.

¹é½Å º¸Á¶Á¦ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹é½Å º¸Á¶Á¦ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¹é½Å º¸Á¶Á¦ : À¯Çüº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ¹é½Å º¸Á¶Á¦ : ¿ëµµº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ¹é½Å º¸Á¶Á¦ : Åõ¿©¹ýº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå ¹é½Å º¸Á¶Á¦ ½ÃÀå : Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå °æÀï ±¸µµ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Vaccine Adjuvants Market Growth & Trends:

The global vaccine adjuvants market is expected to reach USD 4.86 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 4.32% from 2025 to 2030. The significance of adjuvant research in the development of vaccines has increased gradually due to inadequate immunogenicity of innovative vaccine antigens. In addition, the growing focus on long-lasting immunization effect against existing and emerging diseases is expected to boost the demand for vaccine adjuvants.

Furthermore, rising prevalence of cervical cancer is anticipated to boost the market. According to NCBI, around 15,000 females die every year due to cervical cancer. There are certain companies developing vaccine adjuvants for this type of cancer in order to enhance the efficacy, such as AS04 adjuvant-adsorbed (human papillomavirus vaccine) by GSK, which boosts the immune response for a longer duration.

Vaccine Adjuvants Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Vaccine Adjuvants Market Variables, Trends & Scope

Chapter 4. Vaccine Adjuvants: Type Estimates & Trend Analysis

Chapter 5. Vaccine Adjuvants: Application Estimates & Trend Analysis

Chapter 6. Vaccine Adjuvants: Administration Estimates & Trend Analysis

Chapter 7. Vaccine Adjuvants Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â